Related Experiment Video
Updated: Jan 16, 2026
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
The Use of Secretome and Exosomes in Cardiovascular Diseases
Eka Ginanjar1, Zahra Nuril Anwar2
1Cardiovascular Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. ekaginanjar.md@gmail.com.
Insights
Secretome and exosomes show promise in treating cardiovascular diseases (CVDs) by aiding tissue repair and reducing inflammation. Further research will unlock their full potential in advanced CVD therapy.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Cell Biology
Background:
- Cardiovascular diseases (CVDs) are a major global health concern.
- Secretome and exosomes are key mediators of intercellular communication.
- Advancements in regenerative medicine highlight their therapeutic potential for CVDs.
Purpose of the Study:
- To elucidate the roles of secretome and exosomes in cardiovascular physiology and pathology.
- To explore the therapeutic applications of secretome and exosomes in mitigating CVD progression.
Main Methods:
- Review of current literature on secretome and exosome function in the cardiovascular system.
- Analysis of their mechanisms in intercellular communication, tissue repair, and immunomodulation.
Main Results:
- Secretome and exosomes exhibit significant potential in reducing CVD progression.
- Key mechanisms include inflammation inhibition and promotion of angiogenesis.
- They also play roles in regulating essential biological pathways relevant to cardiovascular health.
Conclusions:
- Secretome and exosomes are promising therapeutic agents for cardiovascular diseases.
- Their roles in intercellular communication, repair, and immunomodulation are critical.
- Further investigation is required to optimize their clinical application in advanced cardiovascular therapies.
Abstract:
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Recent advancements in regenerative medicine have unveiled the promising roles of secretome and exosomes in the treatment of CVDs. In this article, we aim to understand the roles of secretome and exosomes in the cardiovascular system, both in physiological and pathological conditions, and explore the broad applications of secretome and exosomes in mitigating CVD progression. Secretome and exosomes, which play crucial roles in intercellular communication, tissue repair, and immunomodulation, have shown potential in reducing cardiovascular disease progression by inhibiting inflammation, promoting blood vessel growth, and regulating biological mechanisms. Further research is needed to maximize their use in advanced cardiovascular therapy.
Related Concept Videos
01:36Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...